(Q30363454)

English

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.

scientific article published on 10 June 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

0 references

1 reference

based on heuristic

inferred from title

Sinthujan Jegaskanda

1

0 references

object named as

Karen L Laurie

3

0 references

Katherine Kedzierska

object named as

Katherine Kedzierska

7

0 references

Stephen J. Kent

object named as

Stephen J Kent

9

0 references

author name string

Kirsten Vandenberg

2

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Liyen Loh

4

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Marit Kramski

5

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Wendy R Winnall

6

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Steven Rockman

8

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

language of work or name

0 references

publication date

10 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

210

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

1811-1822

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Severe respiratory disease concurrent with the circulation of H1N1 influenza.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010).

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Antibody reactive in antibody‐dependent cell‐mediated cytotoxicity following influenza virus vaccination

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Dynamic of H5N1 virus in Cambodia and emergence of a novel endemic sub-clade.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Cross-reactive neutralizing antibody against pandemic 2009 H1N1 influenza a virus in intravenous immunoglobulin preparations

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Broadly neutralizing antiviral antibodies

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Human infection with a novel avian-origin influenza A (H7N9) virus

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Clinical findings in 111 cases of influenza A (H7N9) virus infection

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Epidemiology of human infections with avian influenza A(H7N9) virus in China.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU334

21 January 2018

Identifiers

10.1093/INFDIS/JIU334

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30363454&oldid=1550127262"